Technique and clinical consequences of sentinel lymph node biopsy in colorectal cancer

Surgical Oncology

Volumn 17, Issue 3, 2008, Pages 183-193

  Bembenek, Andreas ^a   String, Andreas ^a   Gretschel, Stephan ^a   Schlag, Peter M ^a  

^a Section of Pathology   (Germany)

Author keywords

Colon; Colorectal; Lymph node; Micrometastases; Sentinel; Technique

Indexed keywords

CANCER DIAGNOSIS; CANCER SURGERY; COLON CANCER; COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REVIEW; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL;

COLORECTAL NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 50149114277     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.05.003     Document Type: Review

References (71)

1. Cahill R.A. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 194 (2007) 139-140
2. Mukai M., Tajima T., Oida Y., Kishima K., Nakamura M., and Makuuchi H. Experimental model of two-colonoscope surgery for superficially spreading colonic tumors larger than 3 cm in the right colon. Oncol Rep 18 (2007) 629-632
3. Benson III A.B., Schrag D., Somerfield M.R., Cohen A.M., Figueredo A.T., Flynn P.J., et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22 (2004) 3408-3419
4. Chen S.L., and Bilchik A.J. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244 (2006) 602-610
5. Laine G.A., Allen S.J., Katz J., Gabel J.C., and Drake R.E. Outflow pressure reduces lymph flow rate from various tissues. Microvasc Res 33 (1987) 135-142
6. Kitagawa Y., Watanabe M., Hasegawa H., Yamamoto S., Fujii H., Yamamoto K., et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum 45 11 (2002) 1476-1480
7. Tafra L., Lannin D.R., Swanson M.S., Van Eyk B.S., Verbanac K.M., Chua A.N., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 (2001) 51-59
8. Bembenek A., Rau B., Moesta K.T., Markwardt J., Ulmer C., Gretschel S., et al. Sentinel lymph node biopsy in rectal cancer - not yet ready for clinical use and practice. Surgery 135 (2004) 498-505
9. Tsopelas C., Meijer S., and Pijpers R. Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 43 (2002) 1377-1382
10. Saha S., Wiese D., Badin J., Beutler T., Nora D., Ganatra B.K., et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 7 (2000) 120-124
11. Saha S. Selective lymph node mapping in colorectal cancer-a prospective study for impact on staging, limitations and pitfalls. Cancer Treat Res 111 (2002) 109-116
12. Bembenek A., Rosenberg R., Wagler E., Gretschel S., Sendler A., Siewert J.R., et al. Sentinel lymph node biopsy in colon cancer-a prospective multicenter trial. Ann Surg 245 (2007) 858-863
13. Efron P., Knudsen E., Hirshorn S., and Copeland E.M. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. Breast J 8 (2002) 396-399
14. Meyer J.S. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 69 (1998) 212-218
15. Cady B. Regional lymph node metastases; a singular manifestation of the process of clinical metastases in cancer: contemporary animal research and clinical reports suggest unifying concepts. Ann Surg Oncol 14 (2007) 1790-1800
16. Iddings D., Ahmad A., Elashoff D., and Bilchik A. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 13 (2006) 1386-1392
17. Rosenberg R., Hoos A., Mueller J., Baier P., Stricker D., Werner M., et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 20 (2002 Feb 15) 1049-1055
18. Bilchik A.J., DiNome M., Saha S., Turner R., Wiese D., McCarter M., et al. Prospective multicenter trial of staging adequacy in colon cancer. Arch Surg 141 (2006) 527-534
19. Saha S., Seghal R., Patel M., Doan K., Dan A., Bilchik A., et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191 (2006) 305-310
20. Saha S., Dan A.G., Viehl C.T., Zuber M., and Wiese D. Sentinel lymph node mapping in colon and rectal cancer: its impact on staging, limitations, and pitfalls. Cancer Treat Res 127 (2005) 105-122
21. Terwisscha van Scheltinga S.E.J., Den Boer F.C., Pijpers R., Meyer G.A., Engel A.F., Silvis R., et al. Sentinel node staging in colon carcinoma: value of sentinel lymph node biopsy with radiocolloid and blue staining. Scand J Gastroenterol 41 (2006) 153-157
22. Trocha S.D., Nora D.T., Saha S.S., Morton D.L., Wiese D., and Bilchik A.J. Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 7 (2003) 340-346
23. Soltesz E.G., Kim S., Kim S.-W., Laurence R.G., De Grand A.M., Parungo C.P., et al. Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Ann Surg Oncol (2006) [Epub ahead of print]
24. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York
25. Bilchik A.J., Nora D.T., Sobin L.H., Turner R.R., Trocha S., Krasne D., et al. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol 21 (2003) 668-672
26. Doekhie F.S., Peeters K.C., Tollenaar R.A., and van de Velde C.J.H. Minimal residual disease assessment in sentinel nodes of breast and gastrointestinal cancer: a plea for standardization. Ann Surg Oncol 11 (2004) 236S-241S
27. Wyckoff J.B., Jones J.G., Condeelis J.S., and Segall J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60 (2000 May 1) 2504-2511
28. Meng S., Tripathy D., Frenkel E.P., Shete S., Naftalis E.Z., Huth J.F., et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10 (2004 Dec 15) 8152-8162
29. Mehlen P., and Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 6 (2006) 449-458
30. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2001) 192-198
31. LeBedis C., Chen K., Fallavollita L., Boutros T., and Brodt P. Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 100 (2002 Jul 1) 2-8
32. Townson J.L., and Chambers A.F. Dormancy of solitary metastatic cells. Cell Cycle 5 (2006) 1744-1750
33. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
34. Morrissey C., True L.D., Roudier M.P., Coleman I.M., Hawley S., Nelson P.S., et al. Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis (2007 Oct 31) 10.1007/s10585-007-9116-4
35. Naumov G.N., MacDonald I.C., Weinmeister P.M., Kerkvliet N., Nadkarni K.V., Wilson S.M., et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62 (2002 Apr 1) 2162-2168
36. Shields J.D., Fleury M.E., Yong C., Tomei A.A., Randolph G.J., and Swartz M.A. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11 (2007) 526-538
37. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006 Feb 9) 610-621
38. Demicheli R., Biganzoli E., Boracchi P., Greco M., Hrushesky W.J., and Retsky M.W. Allometric scaling law questions the traditional mechanical model for axillary lymph node involvement in breast cancer. J Clin Oncol 24 (2006 Sep 20) 4391-4396
39. Madbouly K.M., Senagore A.J., Mukerjee A., Delaney C.P., Connor J., and Fazio V.W. Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease?. Int J Colorectal Dis 22 (2007) 39-48
40. Bembenek A., Schneider U., Gretschel S., Fischer J., and Schlag P.M. Detection of lymph-node micrometastases and isolated tumor cells in sentinel and non-sentinel lymph nodes of colon-cancer patients. World J Surg 29 (2005) 1172-1175
41. Turner R.R., Nora D.T., Trocha S.D., and Bilchik A.J. Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med 127 (2003) 673-679
42. Joosten J.J.A., Strobbe L.J.A., Wauters C.A.P., Pruszczynski M., Wobbes T., and Ruers T.J.M. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 86 (1999) 482-486
43. Broderick-Villa G., Ko A., ThX O., Guenther J.M., Danial T., and DiFronzo L.A. Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer?. Cancer J 8 (2002) 445-450
44. Paramo J.C., Summerall J., Poppiti R., and Mesko T.W. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 9 (2002) 550-554
45. Fleig B.W., Curley S., Lucci A., Hunt K.K., Vauthey J.N., Mansfield P.F., et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 182 (2001) 707-712
46. Saha S., Bilchik A., Wiese D., Espinosa M., Badin J., Ganatra B.K., et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique - a multicenter trial. Ann Surg Oncol 8 (2001) 94-98
47. Saha S., Monson K.M., Bilchik A., Beutler T., Dan A.G., Schochet E., et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trail. Dis Colon Rectum 47 (2004) 1767-1772
48. Bembenek A., Schneider U., Gretschel S., Ulmer C., and Schlag P. Aktuelle Aspekte des Stagings beim Kolonkarzinom durch die Sentinel-Lymphknotenbiopsie. Chirurg (2004)
49. Bertagnolli M., Miedema B., Redston M., Dowell J., Niedzwiecki D., Fleshman J., et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 240 (2004) 624-630
50. Bell S.W., Mourra N., Flejou J.F., Parc R., and Tiret E. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis Colon Rectum 48 1 (2005) 74-79
51. Thomas K.A., Lechner J., Shen P., Waters G.S., Geisinger K.R., and Levine E.A. Use of sentinel node mapping for cancer of the colon: "to map or not to map". Am Surg 72 (2006) 606-611
52. Stojadinovic A., Nissan A., Protic M., Adair C.F., Prus D., Usaj S., et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 245 (2007) 846-857
53. Kitagawa Y., Fujii H., Mukai M., Kubota T., Ando N., Watanabe M., et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 80 (2000) 1799-1809
54. Baton O., Lasser P., Sabourin J.C., Boige V., Duvillard P., Elias D., et al. Ex vivo sentinel lymph node study for rectal adenocarcinoma: preliminary study. World J Surg 29 (2005) 1166-1170
55. Yagci G., Unlu A., Kurt B., Can M.F., Kaymakcioglu N., Cetiner S., et al. Detection of micrometastases and skip metastases with ex vivo sentinel node mapping in carcinoma of the colon and rectum. Int J Colorectal Dis 22 (2007) 167-173
56. Greenson J.K., Craig E.I., Rice R., Mojzisik C., Houchens D., and Martin E.W. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 73 (1994) 563-569
57. Jeffers M.D., O'Dowd G.M., Mulcahy H., Stagg M., O'Donoghue D.P., and Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172 (1994) 183-187
58. Adell G., Boeryd B., Franlund B., Sjödahl R., and Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma. Eur J Surg 162 (1996) 637-642
59. Clarke G., Ryan E., Crowe J., O'Keane J.C., and MacMathuna P. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage 2 colorectal cancer. Eur J Histochem 43 (1999) 311-316
60. Tschmelitsch J., Klimstra D.S., and Cohen A.M. Lymph node micrometastases do not predict relapse in stage 2 colon cancer. Ann Surg Oncol 7 (2000) 601-608
61. Noura S., Yamamoto Y., Ohnishi T., Masuda N., Matsumoto T., Takayama O., et al. Comparative detection of lymph node micrometastases of stage 2 colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 20 (2002) 4232-4241
62. Fisher E.R., Colangelo L., Wieand S., Fisher B., and Wolmark N. Lack of influence of cytokeratine-positive mini micrometastases in "negative node" patients with colorectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Projects Protocols R-01 and C-01. Dis Colon Rectum 46 (2003) 1021-1026
63. Rosenberg R., Friederichs J., Gertler R., Hoos A., Mueller J., Nahrig J., et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 19 (2004) 430-437
64. Kronberg U., Lopez-Kostner F., Soto G., Zuniga A., Wistuba I., Miranda V., et al. Detection of lymphatic micrometastases in patients with stages I and II colorectal cancer: impact on five-year survival. Dis Colon Rectum 47 (2004) 1151-1157
65. Lee M.R., Hong C.W., Yoon S.N., Lim S.B., Park K.J., Lee M.J., et al. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer. J Surg Oncol 93 (2006 Jan 1) 13-18
66. Hayashi N., Ito I., Yanagisawa A., Kato Y., Nakamori S., Imaoka S., et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345 (1995 May 20) 1257-1259
67. Belly R.T., Rosenblatt J.D., Steinmann M., Toner J., Sun J., Shehadi J., et al. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer. Clin Colorectal Cancer 1 (2001) 110-116
68. Merrie A.E.H., van Rij A.M., Dennett E.R., Phillips L.V., Yun K., and McCall J.L. Prognostic significance of occult metastases in colon cancer. Dis Colon Rectum 46 (2003) 221-231
69. Bustin S.A., Siddiqi S., Ahmed S., Hands R., and Dorudi S. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 108 (2004 Jan 20) 412-417
70. Ho S.B., Hyslop A., Albrecht R., Jacobson A., Spencer M., Rothenberger D.A., et al. Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Clin Cancer Res 10 (2004 Sep 1) 5777-5784
71. Bilchik A.J., Hoon D.S., Saha S., Turner R.R., Wiese D., DiNome M., et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 246 (2007) 568-575